Get Full Government Meeting Transcripts, Videos, & Alerts Forever!
Committee clears House Bill 29 to floor to update Idaho controlled-substances schedules
Summary
The committee voted to give House Bill 29 a due-pass recommendation. The bill adds multiple synthetic opioids, cannabinoids, benzodiazepines, stimulants and anabolic steroid derivatives to Idaho schedules and places the FDA-approved postpartum depression drug zuranolone (Zulresso/Zuranolone) into schedule 4.
The Senate Health and Welfare Committee voted to send House Bill 29 to the Senate floor with a due-pass recommendation after a presentation by Nikki Chopsky, health professions bureau chief at the Division of Occupational and Professional Licenses.
Chopsky told the committee the Idaho Board of Pharmacy administers the state's Uniform Controlled Substances Act and annually reviews federal scheduling changes because Idaho does not incorporate DEA scheduling…
Already have an account? Log in
Subscribe to keep reading
Unlock the rest of this article — and every article on Citizen Portal.
- Unlimited articles
- AI-powered breakdowns of topics, speakers, decisions, and budgets
- Instant alerts when your location has a new meeting
- Follow topics and more locations
- 1,000 AI Insights / month, plus AI Chat
